NO802913L - Fremgangsmaate ved fremstilling av cephalosporinforbindelse - Google Patents
Fremgangsmaate ved fremstilling av cephalosporinforbindelseInfo
- Publication number
- NO802913L NO802913L NO802913A NO802913A NO802913L NO 802913 L NO802913 L NO 802913L NO 802913 A NO802913 A NO 802913A NO 802913 A NO802913 A NO 802913A NO 802913 L NO802913 L NO 802913L
- Authority
- NO
- Norway
- Prior art keywords
- cephalospor
- procedure
- preparation
- connection
- cephalospor connection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7934204 | 1979-10-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO802913L true NO802913L (no) | 1981-04-03 |
| NO156246B NO156246B (no) | 1987-05-11 |
| NO156246C NO156246C (no) | 1987-08-19 |
Family
ID=10508246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO802913A NO156246C (no) | 1979-10-02 | 1980-10-01 | Fremgangsmaate ved fremstilling av stabilt, krystallinsk pentahydrat av en cephalosporinforbindelse. |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US4329453A (no) |
| JP (1) | JPS5657791A (no) |
| KR (1) | KR840001776B1 (no) |
| AT (1) | AT368161B (no) |
| AU (1) | AU539519B2 (no) |
| BE (1) | BE885489A (no) |
| BG (1) | BG33586A3 (no) |
| CA (1) | CA1142919A (no) |
| CH (1) | CH645118A5 (no) |
| CS (1) | CS214721B2 (no) |
| CY (1) | CY1338A (no) |
| DD (1) | DD153376A5 (no) |
| DE (1) | DE3037102C2 (no) |
| DK (1) | DK155525C (no) |
| EC (1) | ECSP941099A (no) |
| ES (1) | ES8106908A1 (no) |
| FI (1) | FI71157C (no) |
| FR (1) | FR2466467A1 (no) |
| GB (1) | GB2063871B (no) |
| GR (1) | GR69123B (no) |
| HK (1) | HK78686A (no) |
| HU (1) | HU184835B (no) |
| IT (1) | IT1144006B (no) |
| KE (1) | KE3641A (no) |
| MX (1) | MX6545E (no) |
| MY (1) | MY8500315A (no) |
| NL (1) | NL190329C (no) |
| NO (1) | NO156246C (no) |
| PL (1) | PL126606B1 (no) |
| PT (1) | PT71860B (no) |
| RO (1) | RO82721B (no) |
| SE (1) | SE449614B (no) |
| SU (1) | SU942599A3 (no) |
| UA (1) | UA7208A1 (no) |
| YU (1) | YU42357B (no) |
| ZA (1) | ZA806081B (no) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443444A (en) * | 1980-08-11 | 1984-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4427677A (en) | 1980-12-31 | 1984-01-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4474954A (en) * | 1981-12-07 | 1984-10-02 | Bristol-Myers Company | Intermediates for cephalosporin derivatives |
| US4394503A (en) | 1981-12-07 | 1983-07-19 | Bristol-Myers Company | Cephalosporin derivatives |
| JPS58198489A (ja) * | 1982-05-14 | 1983-11-18 | Meiji Seika Kaisha Ltd | ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法 |
| ES8502863A1 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
| DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| DE3313816A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| GB8406218D0 (en) * | 1984-03-09 | 1984-04-11 | Glaxo Group Ltd | Process |
| US4537959A (en) * | 1984-03-26 | 1985-08-27 | Eli Lilly And Company | Crystalline cephalosporin antibiotic salt |
| JPS60231683A (ja) * | 1984-05-02 | 1985-11-18 | Teijin Ltd | セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤 |
| US4616080A (en) * | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
| US4626534A (en) * | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
| DE3577656D1 (de) * | 1984-07-23 | 1990-06-21 | Lilly Co Eli | Pharmazeutische zusammensetzungen von ceftazidim. |
| US4659813A (en) * | 1984-11-08 | 1987-04-21 | Eli Lilly And Company | Crystallization process for ceftazidime derivative |
| ATE60607T1 (de) * | 1984-11-08 | 1991-02-15 | Lilly Co Eli | Verfahren zur herstellung von kristallinischem ceftazidime-pentahydrat. |
| WO1988010263A1 (fr) * | 1987-06-25 | 1988-12-29 | Banyu Pharmaceutical Co., Ltd. | Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes |
| US4994451A (en) * | 1988-01-19 | 1991-02-19 | Bristol-Myers Company | Cephalosporin salts and injectable compositions |
| US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| AT387390B (de) * | 1986-10-07 | 1989-01-10 | Biochemie Gmbh | Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy |
| US4954624A (en) * | 1986-10-07 | 1990-09-04 | Sandoz Ltd. | Process for the production of cephalosporin derivatives |
| ES2032543T3 (es) * | 1987-02-02 | 1993-02-16 | Eli Lilly And Company | Procedimiento mejorado de preparacion de un antibiotico. |
| US5021564A (en) * | 1987-02-02 | 1991-06-04 | Eli Lilly And Company | Process for preparing ceftazidime pentahydrate |
| WO1988010262A1 (en) * | 1987-06-25 | 1988-12-29 | Banyu Pharmaceutical Co., Ltd. | Crystalline cephalosporin compound |
| GB8802622D0 (en) * | 1988-02-05 | 1988-03-02 | Glaxo Group Ltd | Chemical compound |
| KR940000112B1 (ko) * | 1990-07-05 | 1994-01-05 | 주식회사 대웅제약 | 신규의 3-치환 세펨화합물 및 그의 제조방법 |
| US5831085A (en) * | 1997-01-16 | 1998-11-03 | Lupin Laboratories Limited | Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof |
| CN1328281C (zh) * | 2004-11-16 | 2007-07-25 | 广州白云山制药股份有限公司 | 头孢他啶的纯化方法 |
| CN102875576A (zh) * | 2012-10-31 | 2013-01-16 | 苏州致君万庆药业有限公司 | 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法 |
| CN102924483B (zh) * | 2012-10-31 | 2015-06-17 | 海南合瑞制药股份有限公司 | 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物 |
| CN104876949A (zh) * | 2015-05-28 | 2015-09-02 | 浙江长典医药有限公司 | 一种小儿用头孢他啶化合物实体及其制剂 |
| CN106420658A (zh) * | 2016-09-23 | 2017-02-22 | 临沂草之美医药科技有限公司 | 一种治疗外科手术感染的药物头孢他啶胶囊 |
| CN109111467A (zh) * | 2017-06-22 | 2019-01-01 | 宁应 | 一种51/4水头孢他啶化合物及其药物组合物制剂 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
-
1980
- 1980-09-09 US US06/185,883 patent/US4329453A/en not_active Expired - Lifetime
- 1980-10-01 YU YU2497/80A patent/YU42357B/xx unknown
- 1980-10-01 FI FI803126A patent/FI71157C/fi not_active IP Right Cessation
- 1980-10-01 IT IT49783/80A patent/IT1144006B/it active Protection Beyond IP Right Term
- 1980-10-01 SU SU802987392A patent/SU942599A3/ru active
- 1980-10-01 AT AT0490080A patent/AT368161B/de not_active IP Right Cessation
- 1980-10-01 GB GB8031703A patent/GB2063871B/en not_active Expired
- 1980-10-01 PL PL1980227019A patent/PL126606B1/pl unknown
- 1980-10-01 JP JP13822480A patent/JPS5657791A/ja active Granted
- 1980-10-01 SE SE8006861A patent/SE449614B/sv not_active IP Right Cessation
- 1980-10-01 UA UA2987392A patent/UA7208A1/uk unknown
- 1980-10-01 BE BE0/202301A patent/BE885489A/fr not_active IP Right Cessation
- 1980-10-01 PT PT71860A patent/PT71860B/pt unknown
- 1980-10-01 DE DE3037102A patent/DE3037102C2/de not_active Expired
- 1980-10-01 DD DD80224266A patent/DD153376A5/de not_active IP Right Cessation
- 1980-10-01 MX MX809068U patent/MX6545E/es unknown
- 1980-10-01 GR GR63023A patent/GR69123B/el unknown
- 1980-10-01 RO RO102255A patent/RO82721B/ro unknown
- 1980-10-01 CA CA000361346A patent/CA1142919A/en not_active Expired
- 1980-10-01 NL NLAANVRAGE8005443,A patent/NL190329C/xx not_active IP Right Cessation
- 1980-10-01 FR FR8021033A patent/FR2466467A1/fr active Granted
- 1980-10-01 HU HU802393A patent/HU184835B/hu unknown
- 1980-10-01 ES ES495534A patent/ES8106908A1/es not_active Expired
- 1980-10-01 AU AU62882/80A patent/AU539519B2/en not_active Expired
- 1980-10-01 NO NO802913A patent/NO156246C/no unknown
- 1980-10-01 BG BG049206A patent/BG33586A3/xx unknown
- 1980-10-01 CS CS806627A patent/CS214721B2/cs unknown
- 1980-10-01 ZA ZA00806081A patent/ZA806081B/xx unknown
- 1980-10-01 CY CY1338A patent/CY1338A/en unknown
- 1980-10-01 DK DK414780A patent/DK155525C/da not_active IP Right Cessation
- 1980-10-01 CH CH734180A patent/CH645118A5/de not_active IP Right Cessation
- 1980-10-02 KR KR1019800003810A patent/KR840001776B1/ko not_active Expired
-
1985
- 1985-12-30 MY MY315/85A patent/MY8500315A/xx unknown
-
1986
- 1986-05-29 KE KE3641A patent/KE3641A/xx unknown
- 1986-10-16 HK HK786/86A patent/HK78686A/xx not_active IP Right Cessation
-
1994
- 1994-05-26 EC EC1994001099A patent/ECSP941099A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO801155L (no) | Fremgangsmaate ved fremstilling av acyl-carnitinamider | |
| NO802913L (no) | Fremgangsmaate ved fremstilling av cephalosporinforbindelse | |
| NO800830L (no) | Fremgangsmaate ved fremstilling av glycinamidderivater | |
| NO148281C (no) | Fremgangsmaate ved fremstilling av allergenholdige forbindelser | |
| NO781082L (no) | Fremgangsmaate ved fremstilling av jodofore forbindelser | |
| NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
| NO810014L (no) | Fremgangsmaate ved fremstilling av kikhostetoksoid | |
| NO801775L (no) | Fremgangsmaate ved fremstilling av hypocholesteremiske forbindelser | |
| NO773682L (no) | Fremgangsmaate ved fremstilling av furocumariner | |
| NO151895C (no) | Fremgangsmaate for fremstilling av pyrido-indolderivater | |
| NO151197C (no) | Fremgangsmaate for fremstilling av diester-diamider | |
| NO150155C (no) | Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser | |
| NO802349L (no) | Fremgangsmaate for fremstilling av titanforbindelser | |
| NO780777L (no) | Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer | |
| NO820281L (no) | Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider | |
| NO146656C (no) | Fremgangsmaate ved fremstilling av xylitolholdige drops | |
| NO803247L (no) | R fremgangsmaate ved fremstilling av nye pyridothienotriazine | |
| NO802834L (no) | Fremgangsmaate ved fremstilling av 2-amino-3-benzoyl-fenylacetamider | |
| NO801982L (no) | Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater | |
| NO802435L (no) | Fremgangsmaate til fremstilling av tetrahydrokinolinderivater | |
| NO812467L (no) | Fremgangsmaate ved fremstilling av as-triazinderivater | |
| NO147310C (no) | Fremgangsmaate for fremstilling av substituerte antitumorantracykliner | |
| NO791220L (no) | Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner | |
| NO794090L (no) | Fremgangsmaate for fremstilling av klordioksyd | |
| NO151933C (no) | Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme pyridoksinderivater |